Monopar Therapeutics — Director's Dealing 2018

Jan 9, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Monopar Therapeutics (NONE)
CIK: 0001645469
Period of Report: 2018-01-08

Reporting Person: Tactic Pharma LLC (N/A)
Reporting Person: Mazar Andrew Paul (N/A)
Reporting Person: Robinson Chandler (N/A)
Reporting Person: O'Halloran Thomas V. (N/A)
Reporting Person: Brown Michael J (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	4111272.88	Indirect
Common stock	166667	Direct

Footnotes

F1: This Form 3 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.

F2: Tactic shares voting and investment power over 4,111,272.88 of the shares of common stock held by TacticGem LLC.